SEARCH

SEARCH BY CITATION

References

  • AKIYAMA, N., HIRAOKA, O., FUJII, Y., TERASHIMA, H., SATOH, M., WADA, K. & FURUICHI, Y. (1992). Biotin derivatives of endothelin: utilization for affinity purification of endothelin receptor. Protein Expression Purification, 3, 427433.
  • BAX, W.A., BRUINVELS, A.T., van SUYLEN, R.-J., SAXENA, P.R. & HOYER, D. (1993). Endothelin receptors in the human coronary artery, ventricle and atrium. A quantitative autoradiographic analysis. Naunyn-Schmiedeberg's Arch Pharmacol., 348, 403410.
  • BECKER, A., HAENDLER, B., HECHLER, U. & SCHLEUNING, W.-D. (1994). Mutational analysis of human endothelin receptors ETA and ETB. Identification of regions involved in the selectivity for endothelin 3 or cyclo-(D-Trp-D-Asp-Pro-D-Val-Leu). Eur. J. Biochem., 221, 951958.
  • BUCHAN, K.W., ALLDUS, C., CHRISTODOULOU, C., CLARK, K.L., DYKES, C.W., SUMNER, M.J., WALLACE, D.M., WHITE, D.G. & WATTS, I.S. (1994). Characterization of three non-peptide endothelin receptor ligands using human cloned ETA and ETB receptors. Br. J. Pharmacol., 112, 12511257.
  • COCKCROFT, J.R., CLARKE, J.G. & WEBB, D.J. (1991). The effect of intra-arterial endothelin on resting blood flow and sympathetically mediated vasoconstriction in the forearm of man. Br. J. Clin. Pharmacol., 31, 521524.
  • DAVENPORT, A.P., KUC, R.E., FITZGERALD, F., MAGUIRE, J.J., BERRYMAN, K. & DOHERTY, A.M. (1994). [125 I]-PD151242: a selective radioligand for human ETA receptors. Br. J. Pharmacol., 111, 46.
  • DAVENPORT, A.P. & MAGUIRE, J.J. (1994). Is endothelin-induced vasoconstriction mediated only by ETA receptors in humans? Trends Pharmacol. Sci., 15, 911.
  • DAVENPORT, A.P., O'REILLY, G. & KUC, R.E. (1995). Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type. Br. J. Pharmacol., 114, 11101116.
  • HE, J.X., CODY, W.L., FLYNN, M.A., WELCH, K.M., REYNOLDS, E.E. & DOHERTY, A.M. (1995). RES-701–1, synthesis and a reevaluation of its effects on the endothelin receptors. Bioorganic Med. Chem. Lett., 5, 621626.
  • ISHIKAWA, K., IHARA, M., NOGUCHI, K., MASE, T., MINO, N., SAEKI, T., FUKURODA, T., FUKAMI, T., OZAKI, S., NAGASE, T., NISHIKIBE, M. & YANO, M. (1994). Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. U.S.A., 91, 48924896.
  • JARVIS, M.F., ASSAL, A.A. & GESSNER, G. (1994). Pharmacological characterization of the rat cerebellar endothelin B (ETB) receptor using the novel agonist radioligand [125 I]BQ3020. Brain Res., 665, 3338.
  • KOBAYASHI, S., TANG, R., WANG, B., OPGENORTH, T., LANGEN-STROER, P., SHAPIRO, E. & LEPOR, H. (1994). Binding and functional properties of endothelin receptor subtypes in the human prostate. Mol. Pharmacol., 45, 306311.
  • MAGGI, M., VANNELLI, G.B., FANTONI, G., BALDI, E., MAGINI, A., PERI, A., GIANNINI, S., GLORIA, L., del CARLO, P., CASPARIS, D., TOMEI, T. & SERIO, M. (1994). Endothelin in the human uterus during pregnancy. J. Endocrinol., 142, 385396.
  • MAGUIRE, J.J. & DAVENPORT, A.P. (1995). ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro Br. J. Pharmacol., 115, 191197.
  • MAUZY, C., WU, L.-H., EGLOFF, A.M., MIRZADEGAN, T. & CHUNG, F.-Z. (1992). Substitution of lysine-181 to aspartic acid in the third transmembrane region of the endothelin (ET) type B receptor selectivity reduces its high-affinity binding with ET-3 peptide. J. Cardiovasc. Pharmacol., Supp. 12, S5S7.
  • McPHERSON, G.A. (1983). A practical computer-based approach to the analysis of radioligand binding experiments. Comput. Programs Biomed., 17, 107113.
  • MILLER, V. & MICHENER, S.R. (1995). Modulation of contractions to and receptors for endothelins in canine veins. Am. J. Physiol., 268, H345H350.
  • MOLENAAR, P., KUC, R.E. & DAVENPORT, A.P. (1992). Characterization of two new ETB selective radioligands, [125 I]-BQ3020 and [125 I]-Ala1,3,11,15]ET-1 in human heart. Br. J. Pharmacol., 107, 637639.
  • MOLENAAR, P., O'REILLY, G., SHARKEY, A., KUC, R.E., HARDING, D.P., PLUMPTON, C., GRESHAM, A. & DAVENPORT, A.P. (1993). Characterization and localization of endothlin receptor subtypes in the human atrioventricular conducting system and myocardium. Cir. Res., 72, 526538.
  • MORISHITA, Y., CHIBA, S., TSUKUDA, E., TANAKA, T., OGAWA, T., YAMASAKI, M., YOSHIDA, M., KAWAMOTO, I. & MATSUDA, Y. (1994). RES-701–1, a novel and selective endothelin type B receptor antagonist produced by Streptomyces sp. RE-701. 1. Characterization of producing strain, fermentation isolation, physico-chemical and biological properties. J. Antibiotics, 47, 269275.
  • MUNSON, P.J. & RODBARD, D. (1980). LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem., 107, 220239.
  • NAMBI, P. & PULLEN, M. (1995). [125 I]-BQ3020, a potent ETB-selective agonist, displays species differences in its binding characteristics. Neuropeptides, 28, 191196.
  • NAMBI, P., PULLEN, M. & SPIELMAN, W. (1994). Species differences in the binding characteristics of [125 I]IRL-1620, a potent agonist specific for endothelin-B receptors. J. Pharmacol. Exp. Ther., 268, 202207.
  • OZAKI, S., OHWAKI, K., IHARA, M., FUKURODA, T., ISHIKAWA, K. & YANO, M. (1995). ETB-mediated regulation of extracellular levels of endothelin-1 in cultured human endothelial cells. Biochem. Biophys. Res. Commun., 209, 483489.
  • REYNOLDS, E.E., HWANG, O., FLYNN, M.A., WELCH, K.M., CODY, W.L., STEINBAUGH, B., HE, J.X., CHUNG, F.-Z. & DOHERTY, A.M. (1995). Pharmacological differences between rat and human endothelin B receptors. Biochem. Biophys. Res. Commun., 209, 506512.
  • SAKAMOTO, A., YANAGISAWA, M., SAWAMURA, T., ENOKI, T., OHTANI, T., SAKURAI, T., NAKAO, K., TOYO-OKA, T. & MASKI, T. (1993). Distinct subdomains of human endothelin receptors determine their selectivity to endothelin A-selective antagonist and endothelin B-selective agonists. J. Biol. Chem., 268, 85478553.
  • SOGABE, K., NIREI, H., SHOUBO, M., HAMADA, K., NOMOTO, A., HENMI, K., NOTSU, Y. & ONO, T. (1992). A novel endothelial receptor antagonist: studies with FR139317. J. Vasc. Res., 29, 201202.
  • SOKOLOVSKY, M. (1995). Endothelin receptor subtypes and their role in transmembrane signaling mechanisms. Pharmacol. Ther., 68, 435471.
  • TANAKA, T., OGAWA, T. & MATSUDA, Y. (1995). Species difference in the binding characteristics of RES-701–1: potent endothelin ETB receptor-selective antagonist. Biochem. Biophys. Res. Commun., 209, 712716.
  • TANAKA, T., TSUKUDA, E., NOZAWA, M., NONAKA, H., OHNO, T., KASE, H., YAMADA, K. & MATSUDA, Y. (1994). RES-701–1, a novel, potent, endothelin type B receptor selective antagonist of microbial origin. Mol. Pharmacol., 45, 724730.
  • WILLIAMS, D.L. jr., JONES, K.L., COLTON, C.D. & NUTT, R.F. (1991). Identification of high affinity endothelin-1 receptor subtypes in human tissues. Biochem. Biophys. Res. Commun., 180, 475480.
  • YAMAGA, S., TSUTSUMI, K., NIWA, M., KITAGAWA, N., ANDA, T., HIMENO, A., KHALID, H., TANIYAMA, K. & SHIBATA, S. (1995). Endothelin receptor in microvessels isolated from human meningiomas: quantification with radioluminography. Cell. Mol. Neurobiol., 15, 327340.
  • YANO, K., YAMASAKI, M., YOSHIDA, M., MATSUDA, Y. & YAMAGUCHI, K. (1995). RES-701–2, a novel and selective endothelin type B receptor antagonist produced by Streptomyces sp. II. Determination of the primary structure. J. Antibiotics, 48, 13681370.
  • ZHU, G., WU, L.-H., MAUZY, C., EGLOFF, A.M., MIRZADEGAN, T. & CHUNG, F.-Z. (1992). Replacement of lysine-181 by aspartic acid in the third transmembrane region of endothelin type B receptor reduces its affinity to endothelin peptides and sarafotoxin 6c without affecting G protein coupling. J. Cell Biochem., 50, 159164.